Page 206 - metagenics-catalogue_c_en_5
P. 206
Ocudyne
Product description
Our eyes are very sensitive to the damage caused by free radicals. The
production of free radicals is promoted by light and cigarette smoke,
but also especially by watching TV or working at a computer screen. For
people who spend many hours a day in front of the screen, it is very
important to complement the diet with vitamins and antioxidants that support
the eye function. Cristal Clear contains most antioxidants, as well as a
standardized blueberry extract rich in anthocyanes and Ginkgo biloba to
support the blood circulation in the eyes.
Ingredients
INGREDIENTS PER CAPSULE
Calcium citrate 120.00 mg
L-taurine 62.50 mg
Vit. C (ascorbic acid) 62.50 mg 78%*
Marigold extract (Calendula officinalis) 51.00 mg
(5% lutein)
Magnesium (citrate) 45.00 mg
Quercetine 37.50 mg
N-acetyl-L-cystein 31.25 mg
Vit. E (D-alpha tocopherol acetate) 30.00 mg 250%*
Vit. B5 (calcium pantothenate) 12.50 mg 208%*
L- methionine 12.50 mg
Vit. B3 (niacinamid) 7.50 mg 47%*
Ginkgo extract (Ginkgo biloba) 7.50 mg
Zinc (picolinate) 6.25 mg 62,52%*
Glycine 6.25 mg
Glutamic acid 6.25 mg
Blueberry (Vaccinium myrtillus) 5.00 mg
Vit. B6 (pyridoxine HCl) 3.75 mg 271%*
Vit. B2 (riboflavin) 3.13 mg 224%*
Vit. B1 (thiamine HCl) 2.50 mg 227%*
Vit. A 65%*
beta carotene 200.00 µg
retinol palmitate 320.00 µg
Metagenics Europe | info@metagenics.eu | +32(0)59/80.58.24 | www.metagenics.eu Drawn Up 15/12/2012 Ocudyne 4126
The information given in this publication is intended explicitly for readers who deal with health and nutrition on professional grounds. In the interest of public health this publication is not intended
for lay people or consumers. Publisher and authors declare that this publication has been compiled meticulously and to the best of their knowledge. However, they cannot be held responsible for
the comprehensiveness or potential mistakes of this publication. Publisher and authors do not accept any responsibility for damage, of any kind, resulting from actions and/or decisions based on the
contents of this publication.